The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest Stay Legal Selling Peptides Online with 2025 Compliance Tips FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea